General Information of the Compound
| Compound ID |
CP0463312
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-chloro-N-(4-(5-hydroxy-1,3,4-oxadiazol-2-yl)benzyl)-N-(pyridin-2-ylmethyl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H17ClN4O4S
|
||||||||||||||||||
| Molecular Weight |
456.911
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(cc1)S(=O)(=O)N(Cc1ccc(cc1)-c1n[nH]c(=O)o1)Cc1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H17ClN4O4S/c22-17-8-10-19(11-9-17)31(28,29)26(14-18-3-1-2-12-23-18)13-15-4-6-16(7-5-15)20-24-25-21(27)30-20/h1-12H,13-14H2,(H,25,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DNFMCJJMBTYPKK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound